JIR
GDRX icon

James Investment Research’s GoodRx Holdings GDRX Stock Holding History

James Investment Research’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,547
Closed -$200K – 511
2021
Q2 		$200K Sell
5,547
-3,266
-37% -$121K 0.02% 290
2021
Q1 		$344K Buy
8,813
+6,609
+300% +$297K 0.03% 233
2020
Q4 		$89K Buy
+2,204
New +$101K 0.01% 330

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

James Investment Research's GDRX Position: Q3 2021 in Review

James Investment Research sold out of GoodRx Holdings (GDRX) in Q3 2021, closing a stake of 5,547 shares — an estimated $200K sold.

James Investment Research first reported a position in GDRX in Q4 2020 and held it in 3 quarters. The position peaked at $344K in Q1 2021. 218 funds tracked by Wall St. Rank hold GDRX as of Q3 2021.

  • James Investment Research reported no remaining GoodRx Holdings position as of Q3 2021 after selling out during the quarter.
  • James Investment Research sold 5,547 GoodRx Holdings shares in Q3 2021, an estimated $200K.
  • James Investment Research first reported a position in GoodRx Holdings in Q4 2020 and held it in 3 quarters.
  • James Investment Research's GoodRx Holdings position peaked at $344K in Q1 2021.
  • 218 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2021.

Based on James Investment Research's 13F filing for Q3 2021, filed 22 Oct 2021.